Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System

NCT ID: NCT00205881

Last Updated: 2012-03-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-10-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Normal hearing listeners gain important everyday benefits from listening with two ears (bilateral hearing) compared to their baseline performance with hearing aids. Advantages of bilateral hearing include the ability to determine where sounds are coming from and the ability to hear sounds and understand speech in noisy environments. Based upon these advantages, this study will (1) evaluate the benefit of hearing with two Bionic Ear implants (one in each ear) and (2) compare HiResolution sound processing with conventional sound processing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Bilaterally Implanted with HiRes 90K device.

Group Type ACTIVE_COMPARATOR

HiRes 90K Bionic Ear System

Intervention Type DEVICE

Cochlear implant system

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HiRes 90K Bionic Ear System

Cochlear implant system

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. No previous implant experience.
2. Age 18 years or older.
3. Postlingual onset of hearing loss.
4. Sensorineural hearing loss of a severe or greater degree in both ears.
5. Normal/patent cochlear anatomy in each ear.
6. English language proficiency.
7. Willingness and ability to participate in all scheduled procedures.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Advanced Bionics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary Joe Osberger

Role: STUDY_CHAIR

Advanced Bionics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

House Clinic/House Ear Institute

Los Angeles, California, United States

Site Status

California Ear Institute (Let Them Hear Foundation)

Palo Alto, California, United States

Site Status

University of Miami - Cochlear Implant Center

Miami, Florida, United States

Site Status

Tampa Bay Hearing and Balance Center

Tampa, Florida, United States

Site Status

Carle Clinic Association

Urbana, Illinois, United States

Site Status

Spectrum Health

Grand Rapids, Michigan, United States

Site Status

Midwest Ear Institute

Kansas City, Missouri, United States

Site Status

New York University Cochlear Implant Center

New York, New York, United States

Site Status

Dallas Otolaryngology Associates

Dallas, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUD-BL-070705

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Hearing Aid Benefit
NCT05198713 COMPLETED NA